| scholarly article | Q13442814 |
| P50 | author | Arshed A Quyyumi | Q88025136 |
| Peter Wilson | Q89854449 | ||
| Riyaz Patel | Q101382845 | ||
| P2093 | author name string | Stephen E Epstein | |
| Emir Veledar | |||
| Danny J Eapen | |||
| Christina Wassel | |||
| Muhammad Hammadah | |||
| Laurence Sperling | |||
| Pankaj Manocha | |||
| Sergey Sikora | |||
| Dylan Malayter | |||
| Ravi A Nanjundappa | |||
| P2860 | cites work | Prediction of Coronary Heart Disease Using Risk Factor Categories | Q22241923 |
| Evaluating the quality of research into a single prognostic biomarker: a systematic review and meta-analysis of 83 studies of C-reactive protein in stable coronary artery disease | Q28751824 | ||
| Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies | Q29417010 | ||
| Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond | Q29614697 | ||
| Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts | Q33377856 | ||
| Circulating inflammatory and hemostatic biomarkers are associated with risk of myocardial infarction and coronary death, but not angina pectoris, in older men. | Q33606548 | ||
| Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women | Q34067367 | ||
| Plasma levels of Hsp70 and anti-Hsp70 antibody predict risk of acute coronary syndrome | Q34427494 | ||
| Profibrinolytic, antithrombotic, and antiinflammatory effects of an insulin-sensitizing strategy in patients in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial | Q34452976 | ||
| Multiple biomarkers for the prediction of first major cardiovascular events and death | Q34593507 | ||
| Heat shock proteins and their role in heart injury. | Q34925848 | ||
| Clinical application of C-reactive protein for cardiovascular disease detection and prevention | Q35054464 | ||
| Myocardial ischaemia and the inflammatory response: release of heat shock protein 70 after myocardial infarction | Q35583741 | ||
| Biomarkers to predict recurrent cardiovascular disease: the Heart and Soul Study | Q36455014 | ||
| Fibrin(ogen) and its fragments in the pathophysiology and treatment of myocardial infarction | Q36492191 | ||
| Identification of a NF-κB cardioprotective gene program: NF-κB regulation of Hsp70.1 contributes to cardioprotection after permanent coronary occlusion | Q36603095 | ||
| From here to eternity: a unified kinetic model for the pathophysiology of atherosclerotic events | Q36701385 | ||
| Predicting the 30-year risk of cardiovascular disease: the framingham heart study | Q37356527 | ||
| The role of heat shock proteins in protection and pathophysiology of the arterial wall | Q41181626 | ||
| Serum heat shock protein 70 levels predict the development of atherosclerosis in subjects with established hypertension | Q44538250 | ||
| Contribution of novel biomarkers to incident stable angina and acute coronary syndrome: the PRIME Study | Q45796818 | ||
| Stress type dependence of expression and cytoplasmic-nuclear partitioning of glucocorticoid receptor, hsp90 and hsp70 in Wistar rat brain. | Q45972074 | ||
| Circulating surfactant protein-D and the risk of cardiovascular morbidity and mortality | Q46463444 | ||
| Inflammatory markers and long-term risk of ischemic heart disease in men A 13-year follow-up of the Quebec Cardiovascular Study | Q46700751 | ||
| Increased serum levels of heat shock protein 70 are associated with low risk of coronary artery disease | Q47934879 | ||
| Lack of diagnostic and prognostic utility of circulating plasma myeloperoxidase concentrations in patients presenting with dyspnea | Q48841991 | ||
| Multimarker prediction of coronary heart disease risk: the Women's Health Initiative. | Q51699607 | ||
| Fibrinogen and risk of cardiovascular disease. The Framingham Study. | Q52588834 | ||
| High-sensitivity C-reactive protein, vascular imaging, and vulnerable plaque: more evidence to support trials of antiinflammatory therapy for cardiovascular risk reduction. | Q53224589 | ||
| A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association | Q66912818 | ||
| D-dimers in relation to the severity of arteriosclerosis in patients with stable angina pectoris after myocardial infarction | Q73011144 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | circulatory system | Q11068 |
| P304 | page(s) | 329-337 | |
| P577 | publication date | 2013-05-09 | |
| P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
| P1476 | title | Aggregate risk score based on markers of inflammation, cell stress, and coagulation is an independent predictor of adverse cardiovascular outcomes | |
| P478 | volume | 62 |
| Q41627043 | An Aggregate Biomarker Risk Score Predicts High Risk of Near-Term Myocardial Infarction and Death: Findings From BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes). |
| Q38626596 | An integrated approach to coronary heart disease diagnosis and clinical management |
| Q38652838 | Association between oxidative stress and atrial fibrillation. |
| Q26860959 | C-reactive protein and coronary heart disease: all said--is not it? |
| Q44256854 | Cardiovascular Disease Biomarkers and suPAR in Predicting Decline in Renal Function: A Prospective Cohort Study. |
| Q64884856 | Cardiovascular Risk Assessed by Reynolds Risk Score in Relation to Waist Circumference in Apparently Healthy Middle-Aged Population in Montenegro. |
| Q37213203 | Cardiovascular disease following hematopoietic stem cell transplantation: Pathogenesis, detection, and the cardioprotective role of aerobic training |
| Q40114454 | Circulating soluble urokinase plasminogen activator receptor levels and peripheral arterial disease outcomes |
| Q36804738 | Clinical utility of the ratio between circulating fibrinogen and fibrin (ogen) degradation products for evaluating coronary artery disease in type 2 diabetic patients |
| Q47232483 | Cohort profile: the Emory Cardiovascular Biobank (EmCAB). |
| Q92685236 | Comparison of Atorvastatin and Rosuvastatin in Reduction of Inflammatory Biomarkers in Patients with Acute Coronary Syndrome |
| Q38795336 | Effective Information Extraction Framework for Heterogeneous Clinical Reports Using Online Machine Learning and Controlled Vocabularies. |
| Q36872650 | Elevated Levels of Serum Fibrin and Fibrinogen Degradation Products Are Independent Predictors of Larger Coronary Plaques and Greater Plaque Necrotic Core. |
| Q41199627 | Gene expression profiles associated with acute myocardial infarction and risk of cardiovascular death |
| Q54968744 | High-Sensitivity Troponin I Levels and Coronary Artery Disease Severity, Progression, and Long-Term Outcomes. |
| Q34576092 | Higher fibrinogen level is independently linked with the presence and severity of new-onset coronary atherosclerosis among Han Chinese population |
| Q98830214 | Incremental prognostic value of a novel metabolite-based biomarker score in congestive heart failure patients |
| Q47604198 | Inflammatory response to mental stress and mental stress induced myocardial ischemia. |
| Q35705439 | Is Impact of Statin Therapy on All-Cause Mortality Different in HIV-Infected Individuals Compared to General Population? Results from the FHDH-ANRS CO4 Cohort |
| Q49532481 | Marital Status and Outcomes in Patients With Cardiovascular Disease |
| Q45822783 | Meta-Analysis Comparing Rosuvastatin and Atorvastatin in Reducing Concentration of C-Reactive Protein in Patients With Hyperlipidemia |
| Q37670245 | Nature or the natural evolution of plaque: what matters? |
| Q36490437 | Novel Biomarker of Oxidative Stress Is Associated With Risk of Death in Patients With Coronary Artery Disease |
| Q38613760 | Novel biomarkers for cardiovascular risk assessment: current status and future directions |
| Q38854433 | Novel biomarkers of coronary microvascular disease |
| Q38747883 | Pathway-Specific Aggregate Biomarker Risk Score Is Associated With Burden of Coronary Artery Disease and Predicts Near-Term Risk of Myocardial Infarction and Death |
| Q36486011 | Plasma stromal cell-derived factor 1α/CXCL12 level predicts long-term adverse cardiovascular outcomes in patients with coronary artery disease. |
| Q42701714 | Risk of exacerbation following pneumonia in adults with heart failure or chronic obstructive pulmonary disease |
| Q89846943 | Sex Differences in Circulating Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Levels and Adverse Outcomes in Coronary Artery Disease |
| Q35021821 | Sex and age differences in the association of depression with obstructive coronary artery disease and adverse cardiovascular events |
| Q35070791 | Soluble urokinase plasminogen activator receptor level is an independent predictor of the presence and severity of coronary artery disease and of future adverse events |
| Q36356620 | Systemic Inflammatory Markers Are Closely Associated with Atherogenic Lipoprotein Subfractions in Patients Undergoing Coronary Angiography |
Search more.